Recent Posts

UA targeting rhabdomyosarcoma, a rare pediatric cancer with few treatment options

Rhabdomyosarcoma (RMS) is a rare cancer of the skeletal muscle that primarily affects pediatric patients. After diagnosis, about 3 out of 4 patients are cured with standard treatment. Survival rates drop to 17 percent if the disease comes back (recurs) and to 30 percent if it spreads (metastasizes).

Read more: https://www.eurekalert.org/pub_releases/2018-10/uoah-utr103118.php